Algernon Pharmaceuticals (AGNPF) Short Interest Ratio & Short Volume $0.05 -0.01 (-12.42%) As of 03/28/2025 03:05 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock Algernon Pharmaceuticals Short Interest DataAlgernon Pharmaceuticals (AGNPF) has a short interest of 30,500 shares. This marks a -1.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 21,901 shares to cover all short positions.Current Short Interest30,500 sharesPrevious Short Interest30,900 sharesChange Vs. Previous Month-1.29%Dollar Volume Sold Short$1,845.25Short Interest Ratio8.2 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume15,140 sharesAverage Trading Volume21,901 sharesToday's Volume Vs. Average69% Short Selling Algernon Pharmaceuticals? Sign up to receive the latest short interest report for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGNPF Short Interest Over TimeAGNPF Days to Cover Over TimeAGNPF Percentage of Float Shorted Over Time Remove Ads Algernon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202530,500 shares $1,845.25 -1.3%N/A8.2 $0.06 2/28/202530,900 shares $1,940.52 -16.5%N/A2.3 $0.06 2/15/202537,000 shares $2,708.40 +625.5%N/A0.4 $0.07 1/31/20255,100 shares $293.25 +363.6%N/A0.4 $0.06 1/15/20251,100 shares $55.00 No ChangeN/A0.1 $0.05 11/30/20243,000 shares $164.85 No ChangeN/A0.5 $0.05 10/31/20244,200 shares $253.05 -49.4%N/A0.4 $0.06 10/15/20248,300 shares $455.67 No ChangeN/A2 $0.05 9/30/20248,300 shares $559.42 -49.7%N/A0.8 $0.07 9/15/202416,500 shares $1,341.78 -0.6%N/A3.8 $0.08 Get the Latest News and Ratings for AGNPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202416,600 shares $1,328.00 No ChangeN/A1.3 $0.08 8/15/202416,600 shares $1,279.86 -0.6%N/A5.7 $0.08 7/31/202416,700 shares $1,504.67 +4.4%N/A0.6 $0.09 7/15/202416,000 shares $1,472.00 -13.0%N/A6.2 $0.09 6/30/202418,400 shares $1,508.80 +46.0%N/A0.9 $0.08 6/15/202412,600 shares $1,249.16 -58.3%N/A1.4 $0.10 5/31/202430,200 shares $3,473.00 +33.6%N/A1.9 $0.12 5/15/202422,600 shares $2,235.59 -7.8%N/A0.6 $0.10 4/30/202424,500 shares $2,017.33 -40.5%N/A1 $0.08 4/15/202441,200 shares $2,809.84 +34.2%N/A3.1 $0.07 3/31/202430,700 shares $2,517.40 -5.0%N/A4.4 $0.08 3/15/202432,300 shares $2,684.13 +68.2%N/A1.5 $0.08 2/29/202419,200 shares $1,065.60 No ChangeN/A0.3 $0.06 1/15/202440,600 shares $2,541.56 No ChangeN/A1.2 $0.06 12/15/20234,300 shares $259.29 -34.9%N/A0.2 $0.06 11/30/20236,600 shares $421.08 No ChangeN/A0.1 $0.06 7/31/2023800 shares $112.88 +33.3%N/A0.2 $0.14 7/15/2023600 shares $102.00 -95.7%N/A0 $0.17 6/30/202314,100 shares $1,951.44 -45.8%N/A0.5 $0.14 6/15/202326,000 shares $4,420.00 -37.5%N/A0.6 $0.17 5/31/202341,600 shares $6,306.56 +47.5%N/A1.9 $0.15 5/15/202328,200 shares $5,380.56 No ChangeN/A4 $0.19 4/30/202328,200 shares $5,358.00 -14.8%N/A0.9 $0.19 4/15/202333,100 shares $6,130.12 +13.4%N/A1.3 $0.19 3/31/202329,200 shares $5,548.00 +2,333.3%N/A0.7 $0.19 3/15/20231,200 shares $477.00 +50.0%N/A0 $0.40 2/28/2023800 shares $250.00 No ChangeN/A0.2 $0.31 2/15/2023800 shares $1,200.00 No ChangeN/A0.5 $1.50 1/31/2023800 shares $1,245.28 -42.9%N/A0.2 $1.56 1/15/20231,400 shares $2,352.00 No ChangeN/A0.3 $1.68Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. But something even more spectacular is bound to happen. And those who know what to expect could make 12/30/20221,400 shares $2,287.60 -26.3%N/A0.2 $1.63 12/15/20221,900 shares $3,537.80 +18.8%N/A0.5 $1.86 11/30/20221,600 shares $2,896.00 -69.2%N/A0.3 $1.81 11/15/20225,200 shares $11,440.00 +225.0%N/A0.8 $2.20 10/31/20221,600 shares $3,200.00 -23.8%N/A0.2 $2.00 10/15/20222,100 shares $5,000.31 -46.2%N/A0.3 $2.38 9/30/20223,900 shares $11,817.00 -69.1%N/A0.3 $3.03 9/15/202212,600 shares $50,066.10 -28.8%N/A0.5 $3.97 8/31/202217,700 shares $72,570.00 +2,850.0%N/A1.5 $4.10 8/15/2022600 shares $1,899.60 +200.0%N/A0.2 $3.17 7/31/2022200 shares $540.00 -60.0%N/A0 $2.70 7/15/2022500 shares $1,182.50 -87.2%N/A0.3 $2.37 6/30/20223,900 shares $11,349.00 -64.9%N/A1 $2.91 6/15/202211,100 shares $48,618.00 +52.1%N/A2.1 $4.38 5/31/20227,300 shares $30,003.00 No ChangeN/A3 $4.11 3/15/2022100 shares $410.00 No ChangeN/A0 $4.10 2/28/2022100 shares $446.30 No ChangeN/A0 $4.46 1/31/2022500 shares $2,830.00 +150.0%N/A0 $5.66 1/15/2022200 shares $1,344.00 -92.0%N/A0 $6.72 12/31/20212,500 shares $8,275.00 No ChangeN/A0.2 $3.31 11/15/202115,300 shares $79,560.00 +1,175.0%N/A0 $5.20 10/29/20211,200 shares $75.60 +200.0%N/A0 $0.06 10/15/2021400 shares $25.68 -99.3%N/A0 $0.06 9/30/202160,700 shares $4,315.77 +462.0%N/A0.2 $0.07 9/15/202110,800 shares $799.20 +10,700.0%N/A0 $0.07 8/31/2021100 shares $7.75 -100.0%N/A0 $0.08 8/13/2021184,600 shares $18,460.00 +638.4%N/A0.3 $0.10 7/30/202125,000 shares $1,750.00 +101.6%N/A0 $0.07 7/15/202112,400 shares $891.56 -51.9%N/A0 $0.07 6/30/202125,800 shares $2,758.02 +15.2%N/A0 $0.11 6/15/202122,400 shares $2,757.44 -40.6%N/A0 $0.12 5/28/202137,900 shares $5,059.65 -9.1%N/A0.1 $0.13 5/14/202141,700 shares $5,358.45 +24.5%N/A0.1 $0.13 4/30/202133,500 shares $5,025.00 -49.2%N/A0 $0.15 4/15/202165,900 shares $8,507.69 +40.2%N/A0 $0.13 3/31/202147,000 shares $10,885.20 +240.6%N/A0.1 $0.23 3/15/202113,800 shares $3,265.08 -73.7%N/A0 $0.24 2/26/202152,400 shares $14,483.36 No ChangeN/A0 $0.28 1/29/202121,500 shares $4,203.25 +7.5%N/A0 $0.20 1/15/2021178,900 shares $32,508.81 +87.3%N/A0.1 $0.18 12/31/202042,100 shares $7,767.45 -76.5%N/A0 $0.18 12/15/2020178,900 shares $68,339.80 +87.3%N/A0.1 $0.38 11/30/202095,500 shares $18,145.00 +55.5%N/A0.1 $0.19 AGNPF Short Interest - Frequently Asked Questions What is Algernon Pharmaceuticals' current short interest? Short interest is the volume of Algernon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 30,500 shares of AGNPF short. Learn More on Algernon Pharmaceuticals' current short interest. What is a good short interest ratio for Algernon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGNPF shares currently have a short interest ratio of 8.0. Learn More on Algernon Pharmaceuticals's short interest ratio. Is Algernon Pharmaceuticals' short interest increasing or decreasing? Algernon Pharmaceuticals saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 30,500 shares, a decline of 1.3% from the previous total of 30,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Algernon Pharmaceuticals stock? Short selling AGNPF is an investing strategy that aims to generate trading profit from Algernon Pharmaceuticals as its price is falling. AGNPF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Algernon Pharmaceuticals? A short squeeze for Algernon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGNPF, which in turn drives the price of the stock up even further. How often is Algernon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGNPF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Interest Data 4Front Ventures Short Interest Data Agentix Short Interest Data Alvotech Short Interest Data Anthera Pharmaceuticals Short Interest Data AstraZeneca Short Interest Data AVVAA World Health Care Products Short Interest Data AXIM Biotechnologies Short Interest Data Bespoke Extracts Short Interest Data BriaCell Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:AGNPF) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Algernon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Algernon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
